BioCentury | Jul 25, 2016
Strategy

Paving the way

...Korea Intas Pharmaceuticals Ltd. Mkt in India Novartis AG (NYSE:NVS; SIX:NOVN) Registration in U.S., EU Mycenax Biotech Inc....
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

...chg (A) Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai:4747) (B) 12/25/13 ~$6.0 NA $73.7 NA Mycenax Biotech Inc....
BioCentury | Jan 6, 2014
Financial News

Mycenax completes IPO

...NT$843.4 million ($27.8 million) Shares: 13 million Price: NT$65 Shares after offering: 110.3 million Note: Mycenax...
Items per page:
1 - 3 of 3
BioCentury | Jul 25, 2016
Strategy

Paving the way

...Korea Intas Pharmaceuticals Ltd. Mkt in India Novartis AG (NYSE:NVS; SIX:NOVN) Registration in U.S., EU Mycenax Biotech Inc....
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

...chg (A) Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai:4747) (B) 12/25/13 ~$6.0 NA $73.7 NA Mycenax Biotech Inc....
BioCentury | Jan 6, 2014
Financial News

Mycenax completes IPO

...NT$843.4 million ($27.8 million) Shares: 13 million Price: NT$65 Shares after offering: 110.3 million Note: Mycenax...
Items per page:
1 - 3 of 3